Quick Takeaways
- Commodore Capital LP filed SCHEDULE 13G for Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC).
- Disclosed ownership: 7.1%.
- Date of event: 09 Jan 2026.
Commodore Capital LP - 09 Jan 2026 SCHEDULE 13G Report for Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC)
- Filing Manager
- Commodore Capital LP
- Reporting Manager
- Commodore Capital LP
- Symbol
- IPSC
- Shares outstanding
- 183,710,958 shares
- Disclosed Ownership
- 13,043,478 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G
- Filing time
- 16 Jan 2026, 16:23:14 UTC
- Date of event
- 09 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Commodore Capital LP disclosed 7.1% ownership in Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC) on 09 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 16 Jan 2026, 16:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Commodore Capital LP | 7.1% | 13,043,478 | 0 | 13,043,478 | Michael Kramarz | Managing Partner | |
| Commodore Capital Master LP | 7.1% | 13,043,478 | 0 | 13,043,478 | Michael Kramarz | Authorized Signatory | |
| Robert Egen Atkinson | 7.1% | 13,043,478 | 0 | 13,043,478 | Robert Egen Atkinson | Authorized Signatory | |
| Michael Kramarz | 7.1% | 13,043,478 | 0 | 13,043,478 | Michael Kramarz | Authorized Signatory |